0000899243-21-025422.txt : 20210622
0000899243-21-025422.hdr.sgml : 20210622
20210622201053
ACCESSION NUMBER: 0000899243-21-025422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210619
FILED AS OF DATE: 20210622
DATE AS OF CHANGE: 20210622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Golumbeski George
CENTRAL INDEX KEY: 0001586660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39593
FILM NUMBER: 211036919
MAIL ADDRESS:
STREET 1: C/O CELGENE CORP.
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shattuck Labs, Inc.
CENTRAL INDEX KEY: 0001680367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812575858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1018 W. 11TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78703
BUSINESS PHONE: 919-864-2700
MAIL ADDRESS:
STREET 1: 1018 W. 11TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-19
0
0001680367
Shattuck Labs, Inc.
STTK
0001586660
Golumbeski George
C/O SHATTUCK LABS, INC.
500 W. 5TH STREET, SUITE 1200
AUSTIN
TX
78701
1
0
0
0
Stock Option (Right to Buy)
29.34
2021-06-19
4
A
0
3434
0.00
A
2031-06-19
Common Stock
3434
3434
D
This option represents a right to purchase a total of 3,434 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
/s/ Erin Ator Thomson, Attorney-in-Fact for George Golumbeski
2021-06-22